221 related articles for article (PubMed ID: 2031899)
1. Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion.
Urquhart DR; Templeton AA
Br J Obstet Gynaecol; 1991 Apr; 98(4):396-9. PubMed ID: 2031899
[TBL] [Abstract][Full Text] [Related]
2. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
Henshaw RC; Naji SA; Russell IT; Templeton AA
BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
[TBL] [Abstract][Full Text] [Related]
3. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
[TBL] [Abstract][Full Text] [Related]
4. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study.
Henshaw R; Naji S; Russell I; Templeton A
Acta Obstet Gynecol Scand; 1994 Nov; 73(10):812-8. PubMed ID: 7817735
[TBL] [Abstract][Full Text] [Related]
5. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
Howie FL; Henshaw RC; Naji SA; Russell IT; Templeton AA
Br J Obstet Gynaecol; 1997 Jul; 104(7):829-33. PubMed ID: 9236649
[TBL] [Abstract][Full Text] [Related]
6. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.
Henshaw RC; Naji SA; Russell IT; Templeton AA
Hum Reprod; 1994 Nov; 9(11):2167-72. PubMed ID: 7868693
[TBL] [Abstract][Full Text] [Related]
7. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
Cameron IT; Baird DT
Br J Obstet Gynaecol; 1988 Mar; 95(3):271-6. PubMed ID: 3370199
[TBL] [Abstract][Full Text] [Related]
8. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
Ulmann A; Silvestre L; Chemama L; Rezvani Y; Renault M; Aguillaume CJ; Baulieu EE
Acta Obstet Gynecol Scand; 1992 May; 71(4):278-83. PubMed ID: 1322621
[TBL] [Abstract][Full Text] [Related]
9. Experience and acceptability of medical abortion with mifepristone and misoprostol among U.S. women.
Beckman LJ; Harvey SM
Womens Health Issues; 1997; 7(4):253-62. PubMed ID: 9283280
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
Martin CW; Brown AH; Baird DT
Contraception; 1998 Aug; 58(2):99-103. PubMed ID: 9773264
[TBL] [Abstract][Full Text] [Related]
11. Antiprogestin drugs: research and clinical use in Sweden.
Bygdeman M; Swahn ML
Law Med Health Care; 1992; 20(3):157-60. PubMed ID: 1434756
[TBL] [Abstract][Full Text] [Related]
12. Women's evaluation of three early abortion methods.
Holmgren K
Acta Obstet Gynecol Scand; 1992 Dec; 71(8):616-23. PubMed ID: 1336921
[TBL] [Abstract][Full Text] [Related]
13. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
Rodger MW; Baird DT
Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
[TBL] [Abstract][Full Text] [Related]
14. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
Norman JE; Thong KJ; Rodger MW; Baird DT
Br J Obstet Gynaecol; 1992 Jul; 99(7):601-6. PubMed ID: 1525104
[TBL] [Abstract][Full Text] [Related]
15. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
[TBL] [Abstract][Full Text] [Related]
16. Conditions for choosing between drug-induced and surgical abortions.
Bachelot A; Cludy L; Spira A
Contraception; 1992 Jun; 45(6):547-59. PubMed ID: 1617964
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone or vacuum aspiration in termination of early pregnancy.
Legarth J; Peen UB; Michelsen JW
Eur J Obstet Gynecol Reprod Biol; 1991 Sep; 41(2):91-6. PubMed ID: 1936497
[TBL] [Abstract][Full Text] [Related]
18. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care.
Slade P; Heke S; Fletcher J; Stewart P
Br J Obstet Gynaecol; 1998 Dec; 105(12):1288-95. PubMed ID: 9883920
[TBL] [Abstract][Full Text] [Related]
19. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E
Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
